The moonlighting enzyme CD13: old and new functions to target

被引:343
作者
Mina-Osorio, Paola [1 ]
机构
[1] Feinstein Inst Med Res, Autoimmune Dis Ctr, Manhasset, NY 11030 USA
关键词
D O I
10.1016/j.molmed.2008.06.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aminopeptidase N(CD13) is a widely expressed ectoenzyme with functions that do not always depend on its enzymatic activity: an aspect that has been overlooked. Numerous CD13-targeting tools have been developed in the last few years. Several of them are already undergoing clinical trials, and there are promising reports on the effectiveness of others in animal models of disease. However, their efficacy might be obscured by their effects on unrecognized functions of CD13, resulting in unexpected complications. The purpose of this review is (i) to discuss the various functions ascribed to CD13 and the possible mechanisms behind them and (ii) to consider some of the questions that need to be answered to achieve a better understanding of the biological relevance of these functions, a more precise interpretation of the results obtained after their manipulation and a more rational design of CD13-targeting agents.
引用
收藏
页码:361 / 371
页数:11
相关论文
共 112 条
[21]   Enhancement of tumor necrosis factor a antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13) [J].
Curnis, F ;
Sacchi, A ;
Borgna, L ;
Magni, F ;
Gasparri, A ;
Corti, A .
NATURE BIOTECHNOLOGY, 2000, 18 (11) :1185-1190
[22]  
Curnis F, 2002, CANCER RES, V62, P867
[23]   CD13/aminopeptidase N in collagen vascular diseases [J].
Dan, H ;
Tani, K ;
Hase, K ;
Shimizu, T ;
Tamiya, H ;
Biraa, Y ;
Huang, L ;
Yanagawa, H ;
Sone, S .
RHEUMATOLOGY INTERNATIONAL, 2003, 23 (06) :271-276
[24]   Galectin-4 and small intestinal brush border enzymes form clusters [J].
Danielsen, EM ;
vanDeurs, B .
MOLECULAR BIOLOGY OF THE CELL, 1997, 8 (11) :2241-2251
[25]   Aminopeptidase N in arterial hypertension [J].
Danziger, Robert S. .
HEART FAILURE REVIEWS, 2008, 13 (03) :293-298
[26]   Modification of the amino terminus of a class II epitope confers resistance to degradation by CD13 on dendritic cells and enhances presentation to T cells [J].
Dong, X ;
An, B ;
Kierstead, LS ;
Storkus, WJ ;
Amoscato, AA ;
Salter, RD .
JOURNAL OF IMMUNOLOGY, 2000, 164 (01) :129-135
[27]   Single site polymorphisms and alternative splicing of the human CD13 gene -: different splicing frequencies among patients with acute myeloid leukaemia and healthy individuals [J].
Dybkær, K ;
Kristensen, JS ;
Pedersen, FS .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (03) :691-696
[28]  
FAVALORO E, 1993, EXP HEMATOL, V21, P1695
[29]   COEXPRESSION OF HEMATOPOIETIC ANTIGENS ON VASCULAR ENDOTHELIAL-CELLS - A DETAILED PHENOTYPIC ANALYSIS [J].
FAVALORO, EJ ;
MORAITIS, N ;
BRADSTOCK, K ;
KOUTTS, J .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 74 (04) :385-394